Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 2Other hematologic neoplasm 1Lymphoid 1CNS 1

Conditions

Leukemia, Myeloid, Acute 246Precursor Cell Lymphoblastic Leukemia-Lymphoma 147Myelodysplastic Syndromes 141Leukemia, Lymphocytic, Chronic, B-Cell 140Leukemia 128Lymphoma 80Hematologic Neoplasms 77Lymphoma, Non-Hodgkin 73Leukemia, Myelogenous, Chronic, BCR-ABL Positive 67Hodgkin Disease 55Multiple Myeloma 54Myeloproliferative Disorders 37Recurrence 34Lymphoma, Mantle-Cell 29Graft vs Host Disease 28Burkitt Lymphoma 28Lymphoma, B-Cell 26Lymphoma, Follicular 25Leukemia, Biphenotypic, Acute 25Anemia, Refractory, with Excess of Blasts 23Leukemia, Myelomonocytic, Chronic 22Lymphoma, Large B-Cell, Diffuse 21Neoplasms, Plasma Cell 20Lymphoma, B-Cell, Marginal Zone 20Primary Myelofibrosis 19Leukemia, Prolymphocytic 14Leukemia, Myeloid 13Anemia, Aplastic 13Neoplasms 12Leukemia, B-Cell 12

Interventions

Melphalan 2Cyclophosphamide 2Busulfan 2thymoglobulin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Thiotepa 1Rituximab 1Levetiracetam 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
beta-Thalassemia × fludarabine × Other hematologic neoplasm × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡